肺间质改变为主的继发性肺结核的CT诊断价值与疗效评价  

CT Diagnostic Value and Therapeutic Evaluation of Secondary Pulmonary Tuberculosis with Pulmonary Interstitial Change

作　　者：姚燕 YAO Yan(Zhenjiang Third People's Hospital,Jiangsu 212000,China)

机构地区：[1]镇江市第三人民医院

出　　处：《影像技术》2019年第6期45-47,共3页Image Technology

摘　　要：目的:探讨肺间质改变为主的继发性肺结核的CT诊断价值和临床疗效。方法:回顾性分析2017年2月-2019年2月我院收治的100例肺间质改变为主的继发性肺结核患者资料。患者治疗前、治疗后病变的CT特点采用CT和HRCT进行检查,评估治疗效果。结果:患者病灶多发生于双肺上叶,主要特点是大片状的改变以及节段性的分布;通过抗结核治疗,患者的CT征象改变明显,治疗后的9个月和12个月各CT征象的检出率显著低于治疗前(P<0.05)。结论:临床诊断肺间质改变为主的继发性肺结核,CT和HRCT技术显示病变特点的清晰度较高,能够动态评价抗结核治疗的临床疗效。Objective:To investigate the CT diagnostic value and clinical efficacy of secondary pulmonary tuberculosis with pulmonary interstitial changes as the main cause.Methods:The data of 100 cases of secondary pulmonary tuberculosis with pulmonary interstitial changes from February 2017 to February 2019 were retrospectively analyzed.CT and HRCT were used to examine the CT features of the lesions before and after treatment,and to evaluate the therapeutic effect.Results:Most of the lesions occurred in the upper lobes of both lungs,which were characterized by large patches of changes and segmental distribution.After anti-tuberculosis treatment,the CT signs of the patients changed significantly.The detection rate of each CT sign in 9 and 12 months after treatment was significantly lower than that before treatment(P<0.05).Conclusion:CT and HRCT can dynamically evaluate the clinical efficacy of anti-tuberculosis therapy and provide detailed.

关 键 词：肺间质改变 继发性肺结核 CT 

分 类 号：R445.3[医药卫生—影像医学与核医学] R521[医药卫生—诊断学]